Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$34.00 – $64.75
36% from low
Exchange
OTC Link
OS
NOVO NORDISK A/S B NEW
No one on the platform currently holds NONOF.
No tracked institution reports a position in NONOF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-17 | $3.7500 | 2026-08-18 |
| 2026-03-30 | $7.9500 | 2026-03-31 |
| 2025-08-18 | $3.7500 | 2025-08-19 |
| 2025-03-31 | $7.9000 | 2025-04-01 |
| 2024-08-16 | $3.5000 | 2024-08-19 |
| 2024-03-22 | $6.4000 | 2024-03-26 |
| 2023-08-18 | $6.0000 | 2023-08-22 |
| Execution date | Ratio |
|---|---|
| 2023-09-13 | 2-for-1 |
No one on the platform has traded NONOF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$NONOF has a P/E of 15. Lilly has a P/E of 48 ..do the math!
View on StockTwits ↗I found you an Overbought RSI (Relative Strength Index) on the daily chart of Novo Nordisk A/S. Is that bullish or bearish? $NONOF #RsiOverbought #PINK
View on StockTwits ↗$IMMX All pharmaceuticals dropped last week due to $NONOF and $LLY .
View on StockTwits ↗$IMMX All pharmaceuticals dropped last week due to $NONOF and $LLY
View on StockTwits ↗$NONOF hi everyone just got in on this today premarket. Could be a long hold good luck to everyone 🍻
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $293.9B | -4.2% | $21.99 | $19.52–$25.14 | 2.1× | 1 |
| 2027 | $302.6B | +3.0% | $21.70 | $19.26–$24.80 | 2.1× | 1 |
| 2028 | $321.7B | +6.3% | $23.49 | $20.85–$26.85 | 1.9× | 1 |
| 2029 | $348.0B | +8.2% | $26.60 | $23.61–$30.40 | 1.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.77 | $0.94 | +22.8% |
| 2026-05-06 | $0.93 | $1.02 | +10.3% |
| 2026-02-03 | $0.92 | $0.95 | +2.8% |
| 2025-11-05 | $0.77 | $0.71 | -7.9% |
| 2025-08-06 | $0.94 | $0.94 | +0.5% |
| 2025-05-07 | $0.89 | $0.96 | +8.6% |
| 2025-02-05 | $0.83 | $0.88 | +5.9% |
| 2024-11-06 | $0.90 |
| $0.92 |
| +2.5% |
| $90.0B |
| — |
| FSNUYFresenius SE & Co. KGaA | $13.70 | -0.95% | $123.5B | — |
| NVSEFNovartis AG | $157.90 | +0.00% | $300.1B | — |
Source: Financial Modeling Prep · peers by sector/industry